Nexgel Inc (NXGL)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $2.08M
Last updated: Nov 17, 2026 at 10:58 AM ET
Nexgel Inc (NXGL) Stock Forecast
Analysts expect Nexgel (NXGL) to earn -$18.80 per share in the fiscal year ending Dec 31, 2026, on revenue of $15.79M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$4.40.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 53.7%.
- Fiscal year ending Dec 31, 2026
- -$18.80
- EPS consensus, revenue $15.79M
- Fiscal year ending Dec 31, 2027
- -$4.40
- EPS consensus, revenue $24.27M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$18.80 | -$18.80 to -$18.80 | 1 | $15.79M | $15.79M to $15.79M | 1 |
| Dec 31, 2027 | -$4.40 | -$4.40 to -$4.40 | 1 | $24.27M | $24.27M to $24.27M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$4.08 | N/A | 3 | $5.37M | $5.16M to $5.52M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.40.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$18.80 | -$2.40 | -$2.40 | -$2.40 | -$2.40 | N/A |
| Fiscal year ending Dec 31, 2027 | -$4.40 | $8.00 | $8.00 | $8.00 | $8.00 | N/A |
Frequently Asked Questions About NXGL
What is the NXGL stock forecast?
Consensus analyst estimates put Nexgel's EPS at -$18.80 for the fiscal year ending Dec 31, 2026, on revenue of $15.79M.
What EPS do analysts expect from NXGL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$18.80, with estimates from -$18.80 to -$18.80 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$4.40, with estimates from -$4.40 to -$4.40 from 1 analyst.
What revenue do analysts expect from Nexgel next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $15.79M, with estimates from $15.79M to $15.79M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $24.27M, with estimates from $24.27M to $24.27M.
How many analysts cover NXGL?
1 analyst estimates EPS for Nexgel for the fiscal year ending Dec 31, 2026.
NXGL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors